Anneal delivers precision thermal processing for pharmaceutical-grade alloys and glass components — qualifying fill lines, resolving 483 observations, and eliminating dimensional rejection before your launch window closes.
Compliance & Standards
Each engagement is documented in three beats: the failure condition, the thermal protocol, and the measurable outcome. The scroll doesn't persuade through emotion — it persuades through accumulated evidence.
A CMO in New Jersey had qualified a new 100 mL vial-filling line for a biotech client's lyophilized injectable. Post-rebuild, thermal residual stress in the vial shoulder geometry drove dimensional OOS rates to 4.2% — four times the validated threshold — threatening a product launch window with a hard FDA commitment date.
"The firm failed to establish adequate controls for the annealing process used during vial-forming mandrel qualification. Temperature uniformity mapping studies were not performed across the full conveyor width. Stress birefringence testing was not included in the validation protocol."
"We had six weeks. Anneal had seen the same fracture pattern in borosilicate before. The protocol was on our desk in 48 hours."
A Big Pharma API manufacturing site under a consent decree needed to replace a corroded Inconel 625 heat exchanger in a controlled-substance synthesis reactor. The replacement unit arrived with residual fabrication stresses that caused micro-crack propagation at weld heat-affected zones under thermal cycling — a critical failure mode in a GMP-regulated pressure vessel.
"Replacement pressure vessel components shall be subject to documented post-weld heat treatment protocols meeting ASME Section VIII requirements, with full material certification traceability and third-party witness inspection prior to installation and recommissioning."
"The consent decree had no margin for error. Anneal provided ASME-compliant documentation that our third-party auditor accepted on first review."
A glass packaging plant supplying Type II soda-lime vials to a European pharma packager saw dimensional rejection rates spike from 0.9% to 6.8% in the three weeks following a scheduled furnace rebuild. The rebuild had altered the thermal profile in the forming and annealing lehr, introducing asymmetric cooling rates that caused neck-diameter deviation outside the ±0.15 mm tolerance band.
"Neck diameter Cpk declined from 1.42 to 0.61 following furnace recommissioning. Root cause analysis inconclusive. Customer has placed the supplier on quality hold pending corrective action and re-qualification of the lehr temperature profile."
"The lehr had been rebuilt three times before. Nobody had mapped the full cross-section thermal uniformity. Anneal did it in a day."
By the time you've reached this form, you've seen three problems that look like yours — and three outcomes that prove we've solved them. A process engineer reviews every submission. No sales call. No generic proposal.
Download our Pharmaceutical Heat Treatment Guide — 28 pages of protocol references, compliance mapping, and case documentation.